Related by context. All words. (Click for frequent words.) 70 AEGR 65 Phenoptin 65 AEZS 65 BPAX 65 ITMN 65 ATHX 64 ONXX 64 forodesine 64 INCB# [001] 64 CRTX 64 Triolex 64 ocrelizumab 64 JAK inhibitor 64 elotuzumab 64 AVNR 64 Pimavanserin 64 eltrombopag 64 bicifadine 63 Archexin 63 PEG SN# 63 NKTR 63 ISIS # 63 ALXA 63 tezampanel 63 R#/MEM # 63 PROMACTA 63 ARRY 63 rNAPc2 63 Phase 2a 63 LAF# 63 Restanza 63 investigational oral 63 CRx 63 GSK# [001] 62 MGCD# [001] 62 AUXL 62 axitinib 62 Zenvia Phase III 62 IDX# 62 BAY #-# 62 phase 2a 62 Bicifadine 62 aclidinium bromide 62 phase IIb clinical 62 mipomersen 62 CEQ# 62 Traficet EN 62 daclizumab 62 alvimopan 62 Laquinimod 62 PS# [001] 62 Febuxostat 62 lomitapide 62 PEG Interferon lambda 62 VPHM 62 Phase 1b 62 CIMZIA TM 62 rilonacept 62 midstage clinical 61 Vivitrex 61 GALNS 61 OXi# 61 pomalidomide 61 PXD# 61 Arqule 61 INCY 61 Phase 2a trial 61 cannabinor 61 Acadia Pharmaceuticals 61 ZYBRESTAT 61 Corlux 61 elagolix 61 Phase 1b trial 61 Zerenex 61 otelixizumab 61 AMRN 61 PDE4 inhibitor 61 ENZN 61 LibiGel ® 61 avanafil 61 sorafenib tablets 61 PEG PAL 61 Cethromycin 61 IMMU 61 eniluracil 61 oral prodrug 61 PRX # 61 ISTODAX 61 aclidinium 61 phase IIa clinical 61 Nasulin 61 Phase IIa trial 61 ponatinib 61 HCV protease inhibitor 61 Cinquil 61 Phase IIa clinical 61 MNTX 61 VRTX 61 atrasentan 61 TTHI 61 SCH # 61 Tasimelteon 61 methylnaltrexone 61 LEVADEX 61 vilazodone 61 Vilazodone 61 phase IIb trial 61 ganetespib 60 Naproxcinod 60 histone deacetylase HDAC inhibitor 60 DVAX 60 VVUS 60 Pivotal Phase 60 POZN 60 apremilast 60 QNEXA 60 ALNY 60 DU #b 60 NBIX 60 Sym# 60 AZILECT R 60 IDIX 60 HGS# 60 PSN# [002] 60 MEDI 60 MAP# 60 INCB# [002] 60 Ambrisentan 60 placebo controlled Phase 60 Gabapentin GR 60 sitaxsentan 60 teduglutide 60 Reverset 60 IMGN 60 OPTR 60 teriflunomide 60 MDVN 60 OPXA 60 velafermin 60 ISPH 60 Maribavir 60 YONDELIS 60 ELND# 60 ZGEN 60 Trexima 60 PPHM 60 alvespimycin 60 HDAC Inhibitor 60 GSK# [002] 60 Phase IIa 60 phase IIb 60 orally administered inhibitor 60 Carfilzomib 60 Phase Ib 60 lumiliximab 60 Progenics Pharmaceuticals 60 CORT # 60 NASDAQ REGN 60 oral FTY# 60 HGSI 60 VNDA 60 Vanda Pharmaceuticals 60 Neurodex 60 6R BH4 60 tanespimycin 60 ALTU 60 telcagepant 60 selective modulator 60 Fibrillex TM 60 Milnacipran 60 linaclotide 60 KRN# 60 tasimelteon 60 Elagolix 60 diabetic neuropathic pain 60 Peregrine Pharma 59 mapatumumab 59 MYRX 59 Mipomersen 59 iloperidone 59 dacetuzumab 59 oral opioid modulator 59 Plicera 59 PRT# 59 favorable pharmacokinetic profile 59 CYTR 59 Seattle Genetics SGEN 59 NGX# 59 alagebrium 59 visilizumab 59 dose cohorts 59 AGIX 59 Phase IIb trials 59 HuMax EGFr 59 pramlintide 59 canakinumab 59 AP# [003] 59 atacicept 59 ARQL 59 Azedra 59 ramelteon 59 VAPRISOL 59 Actilon 59 lesinurad 59 phase Ib 59 Immunomedics IMMU 59 Cladribine Tablets 59 indiplon 59 R#/MEM 59 Exenatide 59 tafamidis 59 Levadex 59 AKRX 59 lintuzumab 59 HGS ETR1 59 Arikace 59 AeroLEF TM 59 XmAb# 59 LY# [002] 59 ZIOP 59 Pafuramidine 59 CLDA 59 ACHN 59 Clonicel 59 ruxolitinib 59 Phase IIB 59 Panzem 59 SOMX 59 JAK inhibitors 59 aplindore 59 Ticagrelor 59 polymerase inhibitor 59 Ridaforolimus 59 LymphoStat B 59 Menerba 59 phase IIa 59 edoxaban 59 LY# [003] 59 glufosfamide 59 acting muscarinic antagonist 59 Nasdaq OPTR 59 E2F Decoy 59 CCX# 59 PF # [001] 59 MAGE A3 ASCI 59 Adlea 59 HuMax CD# 59 ALTH 59 Tarceva TM 59 lurasidone 59 Zalbin 59 Synavive 59 evaluating tivozanib 59 CYT# 59 ONTY 59 Rotigotine 59 Aclidinium 59 vicriviroc 59 sapacitabine 59 APTIVUS r 59 octreotide acetate 59 Aegerion 59 virus HCV protease inhibitor 59 BCX# 59 Promacta 59 celgosivir 59 EOquin TM 59 RG# [001] 59 FOLOTYN ® 59 DRRX 59 MNTA 59 REGN 58 ZOLINZA 58 VICL 58 ATL# [001] 58 Symadex 58 Eltrombopag 58 NATRECOR R 58 desvenlafaxine succinate 58 serotonin norepinephrine reuptake inhibitor 58 DepoMed 58 valopicitabine 58 Inhalation Solution 58 safinamide 58 Phase Ib study 58 Targacept TRGT 58 NASDAQ OPTR 58 PTH1 58 Zileuton 58 RSD# 58 elvucitabine 58 CIMZIA ™ 58 denufosol 58 bevirimat 58 EZN 58 Northera 58 Phase Ib clinical 58 inhaled corticosteroid ICS 58 IPL# 58 ARYX 58 Empatic 58 Avanafil 58 Inhibitex INHX 58 Alkermes ALKS 58 Peregrine Pharmaceuticals 58 EMBEDA ™ 58 Nektar Therapeutics NKTR 58 investigational protease inhibitor 58 oral rivaroxaban 58 partial agonist 58 tasocitinib 58 brivaracetam 58 Talabostat 58 Arcalyst 58 Phase IIb Trial 58 QCOR 58 albinterferon alfa 2b 58 Genz # 58 Lacosamide 58 KERX 58 SVNT 58 subcutaneously administered 58 Lu AA# 58 Vion Pharmaceuticals 58 TELINTRA 58 GlycoPEG GCSF 58 riociguat 58 Auxilium Pharmaceuticals 58 AVRX 58 Safinamide 58 registrational 58 desvenlafaxine 58 MNKD 58 orBec 58 oral salmon calcitonin 58 oral methylnaltrexone 58 NVA# 58 SGMO 58 neurogenic orthostatic hypotension 58 pan HDAC inhibitor 58 Huntexil 58 ABIO 58 SUPG 58 Vicriviroc 58 PRTX 58 Ostarine 58 EVIZON 58 liposomal formulation 58 Sapacitabine 58 darapladib 58 RSR# 58 dextromethorphan quinidine 58 Vernakalant 58 Tanespimycin 58 AMLN 58 Phase 2a clinical 58 Keryx Biopharma 58 DYAX 58 Omacetaxine 58 inhaled iloprost 58 Acadia Pharmaceuticals ACAD 58 Exelixis XL# 58 RDEA 58 rFIXFc 58 dose cohort 58 Randomized Phase 58 vidofludimus 58 receptor antagonist 58 nucleoside analog 58 administered subcutaneously 58 MBRX 58 TSRX 58 Phase IIb 58 BARACLUDE R 58 Ziopharm 58 ProSavin 58 Bronchitol 58 Ventavis 58 Guanilib 58 Phase 1a clinical 58 CRME 58 CR# vcMMAE 58 VRUS 58 Perifosine 58 GENZ 58 fostamatinib 58 CB2 selective receptor agonist 58 Rexahn Pharmaceuticals 58 CRXX 58 Glufosfamide 58 trospium 58 IMC A# 58 Regeneron Pharma 58 varespladib 58 Pivotal Phase III 58 investigational compound 58 MEK inhibitor 58 PHX# 58 APTIVUS 58 CLDX 58 rhIGF-I/rhIGFBP-3 58 ongoing Phase 1b 58 crizotinib PF # 58 Forodesine HCl 58 Darusentan 58 NUVIGIL 58 Tyrima 58 Tamibarotene 58 regorafenib 58 Androxal TM 58 asenapine 58 GLPG# 58 MOGN 58 peripherally acting 58 urocortin 2 58 Zelrix 58 Gattex 58 Acorda Therapeutics Inc 58 Relovair 58 GLP1 agonist 58 chronic idiopathic thrombocytopenic purpura 58 SCRX 58 APOPTONE 58 intranasal formulation 57 Saxagliptin 57 TG# [003] 57 EOquin 57 lixisenatide 57 Firazyr 57 LGND 57 ISENTRESS 57 Amigal 57 Rebif ® 57 Bezielle 57 maximally tolerated dose 57 DPP4 inhibitor 57 Allos Therapeutics ALTH 57 Phase IIa trials 57 Nanobody ® 57 adipiplon 57 Aflibercept 57 Serdaxin 57 Solulin 57 Tezampanel 57 Albuferon 57 Onyx Pharma 57 Voreloxin 57 ACTEMRA TM 57 ALGRX 57 Panzem R 57 NASDAQ ONXX 57 Idenix Pharmaceuticals 57 Arena Pharmaceuticals ARNA 57 torezolid phosphate 57 azilsartan medoxomil 57 SinuNase 57 ALN TTR 57 BRIM3 57 Affymax AFFY 57 ularitide 57 HuMax CD4 57 Phase #/#a 57 Phase III Clinical Trials 57 XNPT 57 TBC# 57 Entremed 57 urate lowering 57 ARIKACE ™ 57 XenoPort 57 INTUNIV 57 CYCLOSET 57 reslizumab 57 Blinatumomab 57 ascending dose 57 TPI ASM8 57 TRBN 57 RAPTIVA 57 prodrug stimulant 57 Civacir 57 PhosLo 57 non nucleoside inhibitor 57 Dapagliflozin 57 Indiplon 57 GRN#L 57 metaglidasen 57 Ozarelix 57 JAK2 inhibitor 57 insulin degludec 57 injectable formulation 57 Nasdaq VRTX 57 TMC# [002] 57 Sitagliptin 57 Zoraxel 57 ixabepilone 57 Phase #/#a trial 57 ascending doses 57 HGS ETR2 57 Letairis 57 Solzira 57 long acting muscarinic 57 BioSante Pharmaceuticals 57 blinded randomized placebo controlled 57 SGEN 57 Romidepsin 57 Immunomedics Inc 57 Hematide 57 lintuzumab SGN 57 RGB # 57 Unit Dose Budesonide 57 SHPGY 57 GTOP 57 laquinimod 57 custirsen 57 exenatide LAR 57 confirmatory Phase III 57 Entereg 57 Factor VIIa 57 Vidofludimus 57 SAR# [004] 57 Phase 2b Clinical Trial 57 BENLYSTA ® 57 maribavir 57 ORENCIA R 57 Synta Pharmaceuticals 57 ABII 57 posaconazole 57 blinatumomab 57 ARCOXIA 57 GATTEX 57 Isis Pharmaceuticals ISIS 57 SPC# [001] 57 Iloperidone 57 Phase 2b 57 BRIM2 57 GLYX 57 AVE# 57 sunitinib malate 57 glucokinase activator 57 dosing cohort 57 Ceflatonin R 57 RhuDex 57 LCP Tacro 57 investigational drug 57 AZD# 57 Nektar Therapeutics NASDAQ 57 Elesclomol 57 Immunogen 57 SRT# [003] 57 CCR5 antagonist 57 MERLIN TIMI 57 GRN# 57 integrase inhibitor 57 opioid induced bowel dysfunction 57 dimebon 57 Troxatyl 57 Teriflunomide 57 motesanib 57 Salix Pharmaceuticals NASDAQ SLXP 57 TRIOLEX 57 Zenvia ™ 57 ADX# 57 Amrubicin 57 Cephalon NASDAQ CEPH 57 ABILIFY ® 57 dexpramipexole 57 efalizumab 57 ARIKACE 57 romidepsin 57 DR Cysteamine 57 Dacogen injection 57 Q#IR 57 bosutinib 57 Keryx Biopharmaceuticals 57 Nasdaq AVNR 57 Exenatide LAR 57 Romiplostim 57 Nanobody 57 ENMD 57 voreloxin 57 Belinostat 57 nucleotide analog 57 Adcirca 57 Benlysta belimumab 57 TRGT 57 investigational humanized monoclonal antibody 57 Nuedexta 57 Zenvia TM 57 dosing cohorts 57 Pazopanib 57 satraplatin 57 controlled multicenter Phase 57 Shire plc SHPGY 57 OHR/AVR# 57 cathepsin K inhibitor 57 Antegren 57 tesmilifene 57 CG# [003] 57 Golimumab 57 PSN# [001] 57 apricitabine 57 NASDAQ CLDX 57 darusentan 57 compound INCB# 57 DDP# 57 Chemophase 57 Cypress Biosciences 57 Asentar 57 omacetaxine 57 ridaforolimus 57 RAPAFLO 57 CINOD 57 Xinlay 57 Vandetanib 57 pharmacodynamic 57 Intuniv 57 Gaboxadol 57 PREOS R 57 Array BioPharma ARRY 57 octreotide LAR 56 Zybrestat 56 Entereg alvimopan 56 Phase 2b clinical 56 pramipexole 56 Initiate Phase 56 relapsed MM 56 SCLN 56 exenatide 56 midstage trials 56 dyskinesia PD LID 56 RXII 56 CYT# potent vascular disrupting 56 rasagiline tablets 56 Cytokinetics CYTK 56 Kuvan 56 Sanctura XR 56 gabapentin enacarbil 56 Phase 2b trial 56 Exelixis EXEL 56 HoFH 56 Alfimeprase 56 Gralise 56 tipifarnib 56 registrational trial 56 EnzymeRx 56 eszopiclone 56 refractory APL 56 Nasdaq MBRX 56 CANCIDAS 56 Phase 2a Trial 56 highly selective adenosine 56 Phase III 56 Denosumab 56 NASDAQ VRTX 56 Xcytrin 56 Phase IIa clinical trials 56 naltrexone hydrochloride 56 mecamylamine 56 SNT MC# 56 alemtuzumab Campath 56 Rivaroxaban 56 CA4P 56 Telbivudine 56 CYTX 56 Phase III ALLEGRO 56 clazosentan 56 zileuton CR 56 SNTS 56 CIMZIA TM certolizumab pegol 56 febuxostat 56 Nexavar ® 56 Cannabinor 56 Phase #b/#a 56 RhuDex ® 56 RPRX 56 baminercept 56 squalamine 56 Sulonex 56 Human Genome Sciences HGSI 56 Linaclotide 56 obatoclax 56 subcutaneous formulation 56 receptor partial agonist 56 anticancer compound 56 non nucleoside HCV 56 Meets Primary Endpoint 56 Ocrelizumab 56 sodium glucose cotransporter 56 Phase 2b study 56 HuLuc# 56 Vanda Pharmaceuticals Inc. 56 PREOS 56 Alexion Pharmaceuticals ALXN 56 AEG# 56 Nuvion 56 Levetiracetam 56 Bremelanotide 56 interferon gamma 1b 56 NGSX 56 MLNM 56 REYATAZ R 56 Vertex Pharmaceuticals Inc 56 adecatumumab MT# 56 Panzem R NCD 56 registrational studies 56 albiglutide 56 Regeneron REGN 56 AMEX ANX 56 Biogen Idec NASDAQ BIIB 56 abiraterone acetate 56 Alexza Pharmaceuticals ALXA 56 LymphoStat B TM 56 Urocortin 2 56 PrevOnco 56 alpha antagonist 56 alefacept 56 laropiprant 56 AGILECT R 56 #ME# 56 HCD# [002] 56 class mGluR5 inhibitor 56 Cerovive 56 refractory gout 56 Denufosol 56 MAP Pharmaceuticals 56 Vertex Pharmaceuticals NASDAQ VRTX 56 bifeprunox 56 Desmoteplase 56 picoplatin 56 SinuNase TM 56 Prestara 56 veltuzumab 56 paliperidone palmitate 56 Phase IIIb clinical 56 Serdolect ® 56 JZP 56 TOCOSOL Paclitaxel 56 Ereska 56 Synta Pharmaceuticals SNTA 56 Ceflatonin 56 Phase IIb clinical 56 ATL/TV# 56 deforolimus 56 S/GSK# 56 FM VP4 56 Contrave# 56 active comparator 56 pradefovir 56 TELCYTA 56 volociximab 56 UGNE 56 octreotide 56 Icatibant 56 Viprinex 56 alpha 2A 56 ENCY 56 CDP# 56 DCCR 56 SUTENT ® 56 Annamycin 56 Æterna Zentaris 56 Cloretazine 56 Phase III Pivotal 56 QVA# 56 rotigotine 56 NMDA antagonist 56 Varespladib 56 Targretin 56 angiogenesis inhibitor 56 danoprevir 56 Apoptone 56 GRALISE 56 Proellex 56 synthetic retinoid 56 Telaprevir 56 ABGX 56 Array BioPharma 56 Nasdaq RDEA 56 beta 1a 56 belinostat 56 PREZISTA r 56 ANAVEX #-# [003] 56 dexanabinol 56 GATTEX TM 56 Adentri 56 Inc. NASDAQ ACOR 56 Presents Preclinical 56 NASDAQ SGEN 56 anidulafungin 56 ELACYT 56 GAMMAGARD 56 docetaxel Taxotere R 56 Pralatrexate 56 BIIB 56 XL# [003] 56 highly selective inhibitor 56 antiplatelet agent 56 cancer neuroendocrine tumor 56 ONGLYZA 56 fluticasone furoate 56 IMiDs 56 oral ridaforolimus 56 Cleviprex TM clevidipine 56 Phase 2a Clinical Trial 56 NRGN 56 odanacatib 56 PRADAXA 56 ofatumumab 56 Relivar 56 huC# DM4 56 ACUR 56 PCK# 56 Abbott ABT 56 intravenous dosing 56 HIV integrase inhibitor 56 MDV# 56 MoxDuo IR 56 novel histone deacetylase 56 pharmacodynamic properties 56 AVONEX ® 56 BRAF inhibitor 56 KAPVAY ™ 56 vorinostat 56 THRX 56 TRX1 56 aprepitant 56 Cetrorelix 56 Vaprisol 56 Phase IIIb 56 Factor Xa inhibitor 56 INVEGA ® 56 Inc. NASDAQ AVNR 56 Biogen Idec BIIB 56 Halozyme Therapeutics 56 clevidipine 56 Dalbavancin 56 Durect 56 dirucotide 56 ataluren 56 HMG CoA reductase inhibitors 56 Genentech Roche 56 Oglemilast 56 Bristol Myers BMY 56 olmesartan 56 Amgen NASDAQ AMGN 56 LymphoStat B belimumab 56 NASDAQ VNDA 56 MyVax 56 pegylated interferons 56 EXPAREL TM 56 MAXY G# 56 Orazol 56 Phase III placebo controlled 56 Dasatinib 56 ALN VSP 56 Phase IIb trial 56 SPRYCEL ® 56 PRISTIQ 56 inhaled formulation 56 CPRX 56 pegloticase 56 pivotal Phase III 56 acamprosate 56 Bifeprunox 56 atazanavir sulfate 56 HQK 56 selective A2A adenosine receptor 56 P#X# antagonist 56 sorafenib Nexavar 56 HCV protease inhibitors 56 Zelapar 56 Onyx Pharmaceuticals Inc 56 Sprycel dasatinib 56 Vertex Pharma 56 vemurafenib 56 PD LID 56 talactoferrin 56 Phase 2b clinical trials 56 NASDAQ AVNR 56 CCR5 mAb 56 SGXP 56 Ramelteon 56 delafloxacin 56 REMINYL ® 56 oxymorphone ER 56 USL# 56 edifoligide 55 TYZEKA 55 ALK inhibitor 55 LEVADEX TM 55 OMP #R# 55 BMRN 55 ILLUMINATE 55 Adalimumab 55 Trofex 55 opioid receptor antagonist 55 nonclinical studies 55 VIVITROL ® 55 indacaterol 55 Tesmilifene 55 NXL# 55 Investigational Compound 55 ONTAK 55 receptor agonist 55 Azilect ® 55 dalbavancin 55 NASDAQ BPAX 55 cobiprostone 55 MLN# 55 Betaferon ® 55 Onbrez Breezhaler 55 Vivitrol 55 PDLI 55 romiplostim 55 Bafetinib 55 tocilizumab 55 pseudobulbar affect PBA 55 RDEA# 55 Aptivus ® 55 rosuvastatin calcium 55 perifosine 55 THLD 55 Atiprimod 55 severe gastroparesis 55 Fampridine SR 55 zileuton 55 APD# 55 randomized Phase IIb 55 mGluR5 NAM 55 OncoGel 55 Ranexa 55 Achillion Pharmaceuticals Inc 55 Altus Pharmaceuticals 55 tremelimumab 55 Epanova 55 Furiex Pharmaceuticals 55 Toremifene 55 pharmacodynamic profile 55 SARMs 55 seliciclib 55 telaprevir VX 55 elvitegravir 55 Removab 55 talabostat 55 proteasome inhibitor 55 davunetide 55 Anturol TM 55 Fampridine 55 prucalopride 55 ACOMPLIA R 55 primary hypercholesterolemia 55 relapsed multiple myeloma 55 GATTEX ® 55 FTY# 55 metastatic castration resistant 55 CBLB# 55 Frova ® 55 LEXIVA 55 vandetanib 55 AMYLIN PHARMACEUTICALS 55 inhibitor RG# 55 Neurocrine Biosciences NBIX 55 Preclinical studies suggest 55 Anadys Pharmaceuticals 55 CCX# B 55 ACAPODENE 55 ambrisentan 55 zalutumumab 55 ON #.Na 55 EXEL 55 VEGF Trap 55 mg dose 55 Corcept Therapeutics 55 velafermin belinostat 55 omacetaxine mepesuccinate 55 Telavancin 55 pitavastatin 55 RPTP 55 ICA # 55 Opexa 55 selective androgen receptor modulator 55 DAVANAT R 55 Crizotinib 55 pafuramidine 55 antisense drug 55 NicVAX 55 P#Y# [002] 55 BYDUREON 55 nitazoxanide 55 tecarfarin 55 ALN PCS 55 tezampanel NGX# 55 Avanir Pharmaceuticals 55 MIRCERA 55 Boceprevir 55 NASDAQ NBIX 55 Pharmasset 55 Incyte Corp 55 decitabine 55 TRILIPIX